EFFECT OF 2,3-BUTANEDIONE MONOXIME ON MYOCYTE RESTING FORCE DURING PROLONGED METABOLIC INHIBITION

被引:29
|
作者
IKENOUCHI, H [1 ]
ZHAO, LI [1 ]
BARRY, WH [1 ]
机构
[1] UNIV UTAH,MED CTR,SCH MED,DEPT MED,DIV CARDIOL,SALT LAKE CITY,UT 84132
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1994年 / 267卷 / 02期
关键词
2,3-BUTANEDIONE MONOXIME; ATP DEPLETION; CONTRACTURE; RIGOR;
D O I
10.1152/ajpheart.1994.267.2.H419
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The chemical phosphatase 2,3-butanedione monoxime (BDM) has been reported to inhibit both Ca2+-induced myofilament force development and rigor due to ATP depletion. However, during prolonged hypoxia in cultured ventricular myocytes BDM delays but does not prevent a marked increase in resting force. To investigate the mechanisms involved we measured the effects of BDM on intracellular Ca2+ concentration ([Ca2+](i); indo 1), force development (video motion detector), and ATP contents (luciferase assay) in cultured embryonic chick ventricular myocytes and adult rabbit ventricular myocytes subjected to prolonged metabolic inhibition with 1 mM NaCN and 20 mM 2-deoxyglucose. In the absence of metabolic inhibition, 20 mM BDM depressed force development even when [Ca2+](i) was markedly elevated by exposure to zero-Na solution or 10 mM caffeine in chick cells, and 30 mM BDM completely inhibited Ca2+-induced force development in rabbit myocytes. During metabolic inhibition, 20 mM BDM delayed the onset of an increase in resting force (from 5.44 +/- 0.87 to 13.67 +/- 1.34 min in chick myocytes; from 19.13 +/- 2.23 to 32.43 +/- 3.30 min in rabbit myocytes, means +/- SE, n = 8-9). However, the rates of ATP depletion and rise in [Ca2+](i) after metabolic inhibition were not altered by BDM. In the presence of BDM, during prolonged metabolic inhibition in both chick and rabbit myocytes, abrupt spontaneous or evoked alterations in [Ca2+](i) were associated with corresponding changes in force. During the initial increase in resting force induced by metabolic inhibition, exposure to BDM caused a partial transient relax ation. We conclude that the delayed increase in resting force during metabolic inhibition in the presence of BDM is due to redevelopment of Ca2+ sensitivity of the myofilaments in the presence of an increased [Ca2+](i) as a consequence of severe ATP depletion, whereas in the absence of BDM the more rapidly developing increase in resting force during metabolic inhibition is initially due to a rise in [Ca2+](i) followed by development of rigor.
引用
收藏
页码:H419 / H430
页数:12
相关论文
共 50 条
  • [1] EFFECT OF 2,3-BUTANEDIONE MONOXIME ON MYOCYTE RESTING FORCE DURING PROLONGED METABOLIC INHIBITION
    IKENOUCHI, H
    ZHAO, L
    BARRY, WH
    CLINICAL RESEARCH, 1992, 40 (01): : A72 - A72
  • [2] MECHANISM OF ACTION OF 2,3-BUTANEDIONE MONOXIME ON CONTRACTURE DURING METABOLIC INHIBITION
    HAJJAR, RJ
    INGWALL, JS
    GWATHMEY, JK
    AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (01): : H100 - H108
  • [3] Effects of 2,3-butanedione monoxime on single myocyte calcium release/reuptake during fatiguing contractions
    Howlett, RA
    Hogan, MC
    FASEB JOURNAL, 2004, 18 (05): : A1095 - A1095
  • [4] MULTIPLE EFFECTS OF 2,3-BUTANEDIONE MONOXIME
    SELLIN, LC
    MCARDLE, JJ
    PHARMACOLOGY & TOXICOLOGY, 1994, 74 (06): : 305 - 313
  • [5] 2,3-Butanedione monoxime (BDM) as a myosin inhibitor
    Ostap, EM
    JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 2002, 23 (04) : 305 - 308
  • [6] Effect of 2,3-butanedione monoxime on force of contraction and protein phosphorylation in bovine smooth muscle
    R. Waurick
    J. Knapp
    H. Van Aken
    P. Bokník
    J. Neumann
    W. Schmitz
    Naunyn-Schmiedeberg's Archives of Pharmacology, 1999, 359 : 484 - 492
  • [7] Mechanism of inhibition of cytoplasmic streaming by a myosin inhibitor, 2,3-butanedione monoxime
    M. Tominaga
    E. Yokota
    S. Sonobe
    T. Shimmen
    Protoplasma, 2000, 213 : 46 - 54
  • [8] Effect of 2,3-butanedione monoxime on force of contraction and protein phosphorylation in bovine smooth muscle
    Waurick, R
    Knapp, J
    Van Aken, H
    Bokník, P
    Neumann, J
    Schmitz, W
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1999, 359 (06) : 484 - 492
  • [9] 2,3-Butanedione monoxime (BDM) as a myosin inhibitor
    E. Michael Ostap
    Journal of Muscle Research & Cell Motility, 2002, 23 : 305 - 308
  • [10] Mechanism of inhibition of cytoplasmic streaming by a myosin inhibitor, 2,3-butanedione monoxime
    Tominaga, M
    Yokota, E
    Sonobe, S
    Shimmen, T
    PROTOPLASMA, 2000, 213 (1-2) : 46 - 54